MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer
Launched by SANOFI · Jan 10, 2006
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Main selection criteria:
- • Histologically proven stage Dukes " B2 " (stage II: T3-T4 N0 M0) and " C " (stage III: any T N1-2 M0) colon carcinoma. The inferior pole of the tumor must be above the peritoneal reflection (\> 15 cm from the anal margin)·
- • Complete resection of the primary tumor without gross or microscopic evidence of residual disease
- • Treatment within 7 weeks following surgery
- • Age 18-75 years old
- • ECOG PS £ 2
- • No prior chemo, immuno or radiotherapy
About Sanofi
Sanofi is a global healthcare leader dedicated to empowering life through innovation in pharmaceuticals and vaccines. With a strong commitment to research and development, Sanofi focuses on addressing complex health challenges across various therapeutic areas, including diabetes, oncology, immunology, and rare diseases. The company leverages advanced science and technology to develop transformative therapies that improve patient outcomes. Through collaborative partnerships and a patient-centric approach, Sanofi strives to enhance global health and deliver sustainable solutions that meet the evolving needs of healthcare systems and communities worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Diegem, , Belgium
Paris, , France
Budapest, , Hungary
Natanya, , Israel
Barcelona, , Spain
Bromma, , Sweden
Guildford Surrey, , United Kingdom
Horsholm, , Denmark
Athens, , Greece
Gouda, , Netherlands
Lysaker, , Norway
Warszawa, , Poland
Porto Salvo, , Portugal
Milano, , Italy
Geneva, , Switzerland
Berlin, , Germany
Wien, , Austria
Singapore, , Singapore
Macquarie Park, New South Wales, Australia
Patients applied
Trial Officials
Aimery de Gramont, MD
Study Chair
Hopital saint-Antoine, Oncology department
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials